Selective Wealth Management, Inc. Abb Vie Inc. Transaction History

Selective Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	BUY	$131.98 - $163.75 $83,543 - $103,653	633 Added 94.2%	1,305 $212,000
Q4 2020 Jan 22, 2021	BUY	$80.49 - $108.67 $7,566 - $10,214	94 Added 16.26%	672 $72,000
Q3 2020 Oct 21, 2020	SELL	$85.91 - $100.83 $3,522 - $4,134	-41 Reduced 6.62%	578 $51,000
Q4 2019 Jan 10, 2020	SELL	$72.13 - $90.25 $865 - $1,083	-12 Reduced 1.9%	619 $55,000
Q3 2019 Oct 29, 2019	BUY	$62.98 - $75.72 $39,740 - $47,779	631 New	631 $48,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Selective Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Selective Wealth Management, Inc. with notifications on news.